No Data
No Data
60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations
60 Degrees Pharmaceuticals GAAP EPS of -$4.23
Express News | 60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Financial Results
Express News | HC Wainwright & Co. Reiterates Neutral on 60 Degrees
60 Degrees Analyst Ratings
H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating
No Data
MARKET-TEST-DUMMY OP : where we headed
MARKET-TEST-DUMMY OP : looks like out at 2.48 was it
ProperMicheleV : I can't believe this had a hi today of 2.54. I am not optimistic. but I don't know shit. but I've made money. not on this stock but a few others. some realized some unrealized.